首页> 外文期刊>Bioforum europe >OncoMethylome Sciences Closes European IPO
【24h】

OncoMethylome Sciences Closes European IPO

机译:OncoMethylome Sciences完成欧洲首次公开募股

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OncoMethylome Sciences,a molecular diagnostics company with activities in Belgium,the Netherlands,and the USA,announces the details of its capital increase and listing on the Eurolist by Euronext Brussels and Euronext Amsterdam.Following the subscription to the offered shares,OncoMethylome Sciences will issue 2,933,334 new shares for a total amount of euro 22 million at a price of euro 7.50 per share.In the event that the 15 % over-allotment option is exercised in full,a total amount of euro 25 million will be raised in the of-fering.
机译:一家在比利时,荷兰和美国都有业务的分子诊断公司OncoMethylome Sciences宣布了Euronext Brussels和Euronext Amsterdam增资和在Eurolist上上市的详细信息。在认购所发行股票之后,OncoMethylome Sciences还将发行以每股7.50欧元的价格发行2,933,334股新股,总计2200万欧元。如果全额行使15%的超额配股权,则在以下情况下将总共筹集2500万欧元: fering。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号